OBJECTIVES: Bioactive peptides derived from receptor binding motifs of native proteins are a potent source of bioactive molecules that can induce signalling pathways. These peptides could substitute for osteogenesis promoting supplements. The work presented here compares three kinds of bioactive peptides derived from collagen III, bone morphogenetic protein 7 (BMP-7) and BMP-2 with their potential osteogenic activity on the model of porcine mesenchymal stem cells (pMSCs). MATERIALS AND METHODS: pMSCs were cultured on electrospun polycaprolactone nanofibrous scaffolds with different concentrations of the bioactive peptides without addition of any osteogenic supplement. Analysis of pMSCs cultures included measurement of the metabolic activity and proliferation, immunofluorescence staining and also qPCR. RESULTS: Results showed no detrimental effect of the bioactive peptides to cultured pMSCs. Based on qPCR analysis, the bioactive peptides are specific for osteogenic differentiation with no detectable expression of collagen II. Our results further indicate that peptide derived from BMP-2 protein promoted the expression of mRNA for osteocalcin (OCN) and collagen I significantly compared to control groups and also supported deposition of OCN as observed by immunostaining method. CONCLUSION: The data suggest that bioactive peptide with an amino acid sequence of KIPKASSVPTELSAISTLYL derived from BMP-2 protein was the most potent for triggering osteogenic differentiation of pMSCs.

Faculty of Science Charles University Prague Prague Czech Republic

Institute of Biophysics 2nd Faculty of Medicine Charles University Prague Prague Czech Republic

Laboratory of Tissue Engineering Institute of Experimental Medicine Academy of Sciences of the Czech Republic Prague Czech Republic

University Center for Energy Efficient Buildings Czech Technical University Prague Bustehrad Czech Republic

See more in PubMed

Bernardo ME, Cometa AM, Pagliara D, et al. Ex vivo expansion of mesenchymal stromal cells. Best Pract Res Clin Haematol. 2011;24:73‐81. PubMed

DiGirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: a simple colony‐forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol. 1999;107:275‐281. PubMed

Røsland GV, Svendsen A, Torsvik A, et al. Long‐term cultures of bone marrow–derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Can Res. 2009;69:5331‐5339. PubMed

Vacanti V, Kong E, Suzuki G, Sato K, Canty JM, Lee T. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J Cell Physiol. 2005;205:194‐201. PubMed

Filová E, Rampichová M, Litvinec A, et al. A cell‐free nanofiber composite scaffold regenerated osteochondral defects in miniature pigs. Int J Pharm. 2013;447:139‐149. PubMed

Song SJ, Oju J, Seok YH, Dong‐Keun H, Byung‐Soo K. Effects of culture conditions on osteogenic differentiation in human mesenchymal stem cells. J Microbiol Biotechnol. 2007;17:1113‐1119. PubMed

Park J‐B. The effects of dexamethasone, ascorbic acid, and β‐glycerophosphate on osteoblastic differentiation by regulating estrogen receptor and osteopontin expression. J Surg Res. 2012;173:99‐104. PubMed

Coelho MJ, Fernandes MH. Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, β‐glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials. 2000;21:1095‐1102. PubMed

Curtis KM, Aenlle KK, Roos BA, Howard GA. 24R,25‐Dihydroxyvitamin D(3) promotes the osteoblastic differentiation of human mesenchymal stem cells. Mol Endocrinol. 2014;28:644‐658. PubMed PMC

Wang Y‐K, Yu X, Cohen DM, et al. Bone morphogenetic protein‐2‐induced signaling and osteogenesis is regulated by cell shape, RhoA/ROCK, and cytoskeletal tension. Stem Cells Dev. 2012;21:1176‐1186. PubMed PMC

Yilgor P, Sousa RA, Reis RL, Hasirci N, Hasirci V. Effect of scaffold architecture and BMP‐2/BMP‐7 delivery on in vitro bone regeneration. J Mater Sci Mater Med. 2010;21:2999‐3008. PubMed

Hanada K, Dennis JE, Caplan AI. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein‐2 on osteogenic differentiation of rat bone marrow‐derived mesenchymal stem cells. J Bone Miner Res. 1997;12:1606‐1614. PubMed

Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein‐2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002;84:2123‐2134. PubMed

Friedlaender GE, Perry CR, Dean Cole J, et al. Osteogenic protein‐1 (bone morphogenetic protein‐7) in the treatment of tibial nonunions: a prospective, randomized clinical trial comparing rhOP‐1 with fresh bone autograft*. J Bone Joint Surg Am. 2001;83‐A Suppl 1(Pt 2):S151‐S158. PubMed PMC

Agrawal V, Kelly J, Tottey S, et al. An isolated cryptic peptide influences osteogenesis and bone remodeling in an adult mammalian model of digit amputation. Tissue Eng Part A. 2011;17:3033‐3044. PubMed PMC

Agrawal V, Tottey S, Johnson SA, Freund JM, Siu BF, Badylak SF. Recruitment of progenitor cells by an extracellular matrix cryptic peptide in a mouse model of digit amputation. Tissue Eng Part A. 2011;17:2435‐2443. PubMed PMC

Lee YJ, Lee J‐H, Cho H‐J, Kim HK, Yoon TR, Shin H. Electrospun fibers immobilized with bone forming peptide‐1 derived from BMP7 for guided bone regeneration. Biomaterials. 2013;34:5059‐5069. PubMed

Kim HK, Kim JH, Park DS, et al. Osteogenesis induced by a bone forming peptide from the prodomain region of BMP‐7. Biomaterials. 2012;33:7057‐7063. PubMed

Saito A, Suzuki Y, Ogata S‐i, Ohtsuki C, Tanihara M. Activation of osteo‐progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein‐2 knuckle epitope. Biochim Biophys Acta (BBA) ‐ Proteins Proteom. 2003;1651:60‐67. PubMed

Lee JS, Lee JS, Murphy WL. Modular peptides promote human mesenchymal stem cell differentiation on biomaterial surfaces. Acta Biomater. 2010;6:21‐28. PubMed PMC

Li J‐F, Lin Z‐Y, Zheng Q‐X, et al. Bone formation in ectopic and osteogenic tissue induced by a novel BMP‐2‐related peptide combined with rat tail collagen. Biotechnol Bioproc E. 2010;15:725‐732.

Rampichová M, Koštáková E, Filová E, et al. Non‐woven PGA/PVA fibrous mesh as an appropriate scaffold for chondrocyte proliferation. Physiol Res. 2010;59:773‐781. PubMed

Rao SV, Anderson KW, Bachas LG. Oriented immobilization of proteins. Microchim Acta.128:127‐143.

Kisiel M, Klar AS, Ventura M, et al. Complexation and sequestration of BMP‐2 from an ECM mimetic hyaluronan gel for improved bone formation. PLoS ONE. 2013;8:e78551. PubMed PMC

Dahabreh Z, Calori GM, Kanakaris NK, Nikolaou VS, Giannoudis PV. A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein‐7. Int Orthop. 2009;33:1407‐1414. PubMed PMC

Kisiel M, Ventura M, Oommen OP, et al. Critical assessment of rhBMP‐2 mediated bone induction: An in vitro and in vivo evaluation. J Control Release. 2012;162:646‐653. PubMed

Schneider GB, Zaharias R, Stanford C. Osteoblast integrin adhesion and signaling regulate mineralization. J Dent Res. 2001;80:1540‐1544. PubMed

Carvalho RS, Kostenuik PJ, Salih E, Bumann A, Gerstenfeld LC. Selective adhesion of osteoblastic cells to different integrin ligands induces osteopontin gene expression. Matrix Biol. 2003;22:241‐249. PubMed

Lavery K, Swain P, Falb D, Alaoui‐Ismaili MH. BMP‐2/4 and BMP‐6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow‐derived mesenchymal stem cells. J Biol Chem. 2008;283:20948‐20958. PubMed PMC

Balint E, Lapointe D, Drissi H, et al. Phenotype discovery by gene expression profiling: mapping of biological processes linked to BMP‐2‐mediated osteoblast differentiation. J Cell Biochem. 2003;89:401‐426. PubMed

Lavery K, Hawley S, Swain P, Rooney R, Falb D, Alaoui‐Ismaili MH. New insights into BMP‐7 mediated osteoblastic differentiation of primary human mesenchymal stem cells. Bone. 2009;45:27‐41. PubMed

Anderson JM, Vines JB, Patterson JL, Chen H, Javed A, Jun H‐W. Osteogenic differentiation of human mesenchymal stem cells synergistically enhanced by biomimetic peptide amphiphiles combined with conditioned medium. Acta Biomater. 2011;7:675‐682. PubMed PMC

Hennessy KM, Pollot BE, Clem WC, et al. The effect of collagen I mimetic peptides on mesenchymal stem cell adhesion and differentiation, and on bone formation at hydroxyapatite surfaces. Biomaterials. 2009;30:1898‐1909. PubMed PMC

Mitchell E, Chaffey B, McCaskie A, Lakey J, Birch M. Controlled spatial and conformational display of immobilised bone morphogenetic protein‐2 and osteopontin signalling motifs regulates osteoblast adhesion and differentiation in vitro. BMC Biol. 2010;8:1‐12. PubMed PMC

Chen Y, Webster TJ. Increased osteoblast functions in the presence of BMP‐7 short peptides for nanostructured biomaterial applications. J Biomed Mater Res, Part A. 2009;91:296‐304. PubMed PMC

Rampichová M, Chvojka J, Buzgo M, et al. Elastic three‐dimensional poly (ε‐caprolactone) nanofibre scaffold enhances migration, proliferation and osteogenic differentiation of mesenchymal stem cells. Cell Prolif. 2013;46:23‐37. PubMed PMC

Badami AS, Kreke MR, Thompson MS, Riffle JS, Goldstein AS. Effect of fiber diameter on spreading, proliferation, and differentiation of osteoblastic cells on electrospun poly(lactic acid) substrates. Biomaterials. 2006;27:596‐606. PubMed

Anderson JM, Kushwaha M, Tambralli A, Bellis SL, Camata RP, Jun H‐W. Osteogenic differentiation of human mesenchymal stem cells directed by extracellular matrix‐mimicking ligands in a biomimetic self‐assembled peptide amphiphile nanomatrix. Biomacromol. 2009;10:2935‐2944. PubMed PMC

He X, Yang X, Jabbari E. Combined effect of osteopontin and BMP‐2 derived peptides grafted to an adhesive hydrogel on osteogenic and vasculogenic differentiation of marrow stromal cells. Langmuir. 2012;28:5387‐5397. PubMed

Moore NM, Lin NJ, Gallant ND, Becker ML. Synergistic enhancement of human bone marrow stromal cell proliferation and osteogenic differentiation on BMP‐2‐derived and RGD peptide concentration gradients. Acta Biomater. 2011;7:2091‐2100. PubMed

Olivares‐Navarrete R, Hyzy SL, Haithcock DA, Cundiff CA, Schwartz Z, Boyan BD. Coordinated regulation of mesenchymal stem cell differentiation on microstructured titanium surfaces by endogenous bone morphogenetic proteins. Bone. 2015;73:208‐216. PubMed PMC

Buket Basmanav F, Kose GT, Hasirci V. Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials 2008;29:4195‐4204. PubMed

Tsiridis E, Bhalla A, Ali Z, et al. Enhancing the osteoinductive properties of hydroxyapatite by the addition of human mesenchymal stem cells, and recombinant human osteogenic protein‐1 (BMP‐7) in vitro. Injury. 2006;37(3, Supplement):S25‐S32. PubMed

Shen B, Wei A, Whittaker S, et al. The role of BMP‐7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro. J Cell Biochem. 2010;109:406‐416. PubMed

Shea CM, Edgar CM, Einhorn TA, Gerstenfeld LC. BMP treatment of C3H10T1/2 mesenchymal stem cells induces both chondrogenesis and osteogenesis. J Cell Biochem. 2003;90:1112‐1127. PubMed

Cai P, Xue Z, Qi W, Wang H. Adsorbed BMP‐2 in polyelectrolyte multilayer films for enhanced early osteogenic differentiation of mesenchymal stem cells. Colloids Surf, A. 2013;434:110‐117.

Song Y, Ju Y, Morita Y, Xu B, Song G. Surface functionalization of nanoporous alumina with bone morphogenetic protein 2 for inducing osteogenic differentiation of mesenchymal stem cells. Mater Sci Eng C Mater Biol Appl. 2014;37:120‐126. PubMed

Lai M, Cai K, Zhao L, Chen X, Hou Y, Yang Z. Surface functionalization of TiO2 nanotubes with bone morphogenetic protein 2 and its synergistic effect on the differentiation of mesenchymal stem cells. Biomacromol. 2011;12:1097‐1105. PubMed

Yamashita H, Duke PT, Huylebroeck D, et al. Osteogenic protein‐1 binds to activin type II receptors and induces certain activin‐like effects. J Cell Biol. 1995;130:217‐226. PubMed PMC

Xeno-Hybrid Bone Graft Releasing Biomimetic Proteins Promotes Osteogenic Differentiation of hMSCs